1073319-28-4

Basic information

• Product Name: ethyl (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetate
• Synonyms: ethyl (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetate
• CAS NO: 1073319-28-4
• Molecular Weight: 456.228
• Mol File: 1073319-28-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetate(1073319-28-4)
• EPA Substance Registry System: ethyl (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetate(1073319-28-4)

Safety Data

• Hazardous Substances Data: 1073319-28-4(Hazardous Substances Data)

Upstream product

• 147460-41-1 2-bromo-5-fluorophenol 
• 1073319-24-0 3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazole-5-carboxamide 
• 1073319-23-9 methyl 3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazole-5-carboxylate 
• 1073319-25-1 3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazole-5-carbonitrile 
• 1073318-98-5 2-(2-bromo-5-fluorophenoxy)ethanol 
• 1073319-26-2 5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazole 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 1073318-18-9 (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-2H-tetrazol-2-yl)acetic acid 
• 1073318-19-0 (5-{3-[2-(2-bromo-5-fluorophenoxy)ethoxy]isoxazol-5-yl}-1H-tetrazol-1-yl)acetic acid 

Relevant articles and documents

NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heteroaromatic compounds of structural formula (I) or a pharmaceutically acceptable salt thereof, wherein W is a substituted heteroaryl, X and Y are each independently a bond, -O-, -S-, -S(O)-, -S(O)2-, -NR6-, -C(O)-, -C(CH3)(OH)- or -C(CH3)=CH-, u is an integer from 1 to 4, and Ar is an optionally substituted phenyl or naphtyl, are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD) The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis, obesity, Type 2 diabetes, insulin resistance, hyperglycemia, Metabolic Syndrome, neurological disease, cancer, and liver steatosis